Aristolochic acid nephropathy: what we know and what we have to do.
about
Differential microRNA expression in aristolochic acid-induced upper urothelial tract cancers ex vivo.Chronic kidney disease of unknown etiology in Sri Lanka.Acute nephrotoxicity of aristolochic acid in vitro: metabolomics study for intracellular metabolic time-course changes.JNK-dependent AP-1 activation is required for aristolochic acid-induced TGF-β1 synthesis in human renal proximal epithelial cells.Prevalence and risk factors of chronic kidney disease in first-degree relatives of chronic kidney disease patients in Southern China.Cytotoxicity of phenanthrenes extracted from Aristolochia contorta in human proximal tubular epithelial cell line.
P2860
Aristolochic acid nephropathy: what we know and what we have to do.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Aristolochic acid nephropathy: what we know and what we have to do.
@en
Aristolochic acid nephropathy: what we know and what we have to do.
@nl
type
label
Aristolochic acid nephropathy: what we know and what we have to do.
@en
Aristolochic acid nephropathy: what we know and what we have to do.
@nl
prefLabel
Aristolochic acid nephropathy: what we know and what we have to do.
@en
Aristolochic acid nephropathy: what we know and what we have to do.
@nl
P2860
P1433
P1476
Aristolochic acid nephropathy: what we know and what we have to do.
@en
P2093
Haiyan Wang
Xiaomei Li
P2860
P304
P356
10.1111/J.1440-1797.2004.00252.X
P577
2004-06-01T00:00:00Z